Clinical characteristics of patients who received intravenous GCV and oral VGCV.

GCV, ganciclovir; VGCV, valganciclovir; BMI, body mass index; MELD, model for end-stage liver disease; DDLT, deceased donor liver transplantation; ICU, intensive care unitClinical characteristics of patients who received intravenous GCV and oral VGCV.GCV：更昔洛韦（ganciclovir）；VGCV：缬更昔洛韦（valganciclovir）；BMI：体质量指数（body mass index）；MELD：终末期肝病模型（model for end-stage liver disease）；DDLT：死亡供体肝移植（deceased donor liver transplantation）；ICU：重症监护病房（intensive care unit）。本数据集收录接受静脉输注更昔洛韦与口服缬更昔洛韦患者的临床特征。